{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:27:20Z","timestamp":1761863240060},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.arcped.2013.06.021","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T17:47:01Z","timestamp":1375206421000},"page":"1165-1168","source":"Crossref","is-referenced-by-count":5,"title":["La ph\u00e9nylc\u00e9tonurie\u00a0: nouveaux traitements"],"prefix":"10.1016","volume":"20","author":[{"given":"F.","family":"Feillet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bonnemains","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.arcped.2013.06.021_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1743-7075-9-7","article-title":"Phenylketonuria: nutritional advances and challenges","volume":"9","author":"Giovannini","year":"2012","journal-title":"Nutr Metab"},{"issue":"6","key":"10.1016\/j.arcped.2013.06.021_bib0010","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10545-008-0960-4","article-title":"Long-term compliance with a novel vitamin and mineral supplement in older people with PKU","volume":"31","author":"MacDonald","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.arcped.2013.06.021_bib0015","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-277X.2006.00717.x","article-title":"Home delivery of dietary products in inherited metabolic disorders reduces prescription and dispensing errors","volume":"19","author":"MacDonald","year":"2006","journal-title":"J Hum Nutr Diet"},{"issue":"4","key":"10.1016\/j.arcped.2013.06.021_bib0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10545-006-0234-y","article-title":"\u2019Ready to drink\u2019 protein substitute is easier is for people with phenylketonuria","volume":"29","author":"MacDonald","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.arcped.2013.06.021_bib0025","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ymgme.2011.07.010","article-title":"Oxidative stress in phenylketonuric patients","volume":"104","author":"Vargas","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.arcped.2013.06.021_bib0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nchembio.1002","article-title":"Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria","volume":"8","author":"Adler-Abramovich","year":"2012","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.arcped.2013.06.021_bib0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1542\/peds.2009-3584","article-title":"Challenges and pitfalls in the management of phenylketonuria","volume":"126","author":"Feillet","year":"2010","journal-title":"Pediatrics"},{"issue":"9750","key":"10.1016\/j.arcped.2013.06.021_bib0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2013.06.021_bib0155","series-title":"Plan national de diagnotic et de soins pour la ph\u00e9nylc\u00e9tonurie","author":"HAS","year":"2010"},{"key":"10.1016\/j.arcped.2013.06.021_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/8904_2012_207","article-title":"Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet","volume":"10","author":"Rubin","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.arcped.2013.06.021_bib0055","series-title":"The metabolic & molecular bases of inherited diseases","article-title":"Hyperphenylalaninemia: phenylalanine hydroxylase deficiency","author":"Donlon","year":"2008"},{"issue":"3","key":"10.1016\/j.arcped.2013.06.021_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3476(99)70138-1","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"135","author":"Kure","year":"1999","journal-title":"J Pediatr"},{"issue":"9586","key":"10.1016\/j.arcped.2013.06.021_bib0065","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.arcped.2013.06.021_bib0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2011.03.020","article-title":"Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: results of a phase 3b study","volume":"103","author":"Burton","year":"2011","journal-title":"Mol Genet Metabol"},{"issue":"4","key":"10.1016\/j.arcped.2013.06.021_bib0075","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ymgme.2009.01.002","article-title":"Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria","volume":"96","author":"Blau","year":"2009","journal-title":"Mol Genet Metabol"},{"issue":"4","key":"10.1016\/j.arcped.2013.06.021_bib0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2007.09.017","article-title":"Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment","volume":"92","author":"Levy","year":"2007","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.arcped.2013.06.021_bib0085","unstructured":"Agnecy EM. Kuvan: summary of product characteristics [online]. Disponible sur\u00a0: http:\/\/wwwemaeuropaeu\/docs\/fr_FR\/document_library\/EPAR_-_Product_Information\/human\/000943\/WC500045038pdf 2009."},{"issue":"4","key":"10.1016\/j.arcped.2013.06.021_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003495-200969040-00006","article-title":"Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia","volume":"69","author":"Sanford","year":"2009","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.arcped.2013.06.021_bib0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10545-012-9464-3","article-title":"Efficacy and safety of BH4\u00a0before the age of 4years in patients with mild phenylketonuria","volume":"35","author":"Leuret","year":"2012","journal-title":"J Inherit Metabol Dis"},{"issue":"3","key":"10.1016\/j.arcped.2013.06.021_bib0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jpeds.2010.08.016","article-title":"Tetrahydrobiopterin therapy for phenylketonuria in infants and young children","volume":"158","author":"Burton","year":"2011","journal-title":"J Pediatr"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.arcped.2013.06.021_bib0105","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1016\/S0248-8663(10)70028-X","article-title":"Enzyme replacement therapy of lysosomal storage diseases","volume":"31","author":"Germain","year":"2010","journal-title":"Rev Med Interne"},{"issue":"3","key":"10.1016\/j.arcped.2013.06.021_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymgme.2011.06.016","article-title":"Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria","volume":"104","author":"Sarkissian","year":"2011","journal-title":"Mol Genet Metabol"},{"issue":"52","key":"10.1016\/j.arcped.2013.06.021_bib0115","doi-asserted-by":"crossref","first-page":"20894","DOI":"10.1073\/pnas.0808421105","article-title":"Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"105","author":"Sarkissian","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.arcped.2013.06.021_bib0120","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1172\/JCI5017","article-title":"Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria","volume":"103","author":"Pietz","year":"1999","journal-title":"J Clin Invest"},{"issue":"8447","key":"10.1016\/j.arcped.2013.06.021_bib0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(85)90250-8","article-title":"Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria","volume":"2","author":"Lou","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.arcped.2013.06.021_bib0130","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10545-006-0395-8","article-title":"Large neutral amino acids in the treatment of phenylketonuria (PKU)","volume":"29","author":"Matalon","year":"2006","journal-title":"J Inherit Metabol Dis"},{"key":"10.1016\/j.arcped.2013.06.021_bib0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/8904_2011_96","article-title":"Chaperone-like therapy with tetrahydrobiopterin in clinical trials for phenylketonuria: is genotype a predictor of response?","volume":"5","author":"Sarkissian","year":"2012","journal-title":"JIMD Rep"},{"issue":"8","key":"10.1016\/j.arcped.2013.06.021_bib0140","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1172\/JCI34355","article-title":"Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria","volume":"118","author":"Pey","year":"2008","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.arcped.2013.06.021_bib0145","first-page":"247","article-title":"Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer","volume":"1","author":"Fang","year":"1994","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.arcped.2013.06.021_bib0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jgm.1543","article-title":"Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self-complementary adeno-associated virus vector","volume":"13","author":"Yagi","year":"2011","journal-title":"J Gene Med"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X13003771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X13003771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T03:51:38Z","timestamp":1539489098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X13003771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0929693X13003771"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2013.06.021","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}